$0.93
+0.01 (+1.54%)
Open$0.93
Previous Close$0.92
Day High$0.98
Day Low$0.89
52W High$22.32
52W Low$10.64
Volume—
Avg Volume446.9K
Market Cap154.92M
P/E Ratio27.83
EPS$0.67
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.46M | 45.50M | 43.44M |
| Net Income | 5.47M | 5.03M | 5.89M |
| Profit Margin | 12.3% | 11.1% | 13.6% |
| EBITDA | 8.24M | 9.46M | 8.95M |
| Free Cash Flow | 4.73M | 3.67M | 4.46M |
| Rev Growth | +4.4% | +9.5% | -0.1% |
| Debt/Equity | 0.49 | 0.48 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |